ClinConnect ClinConnect Logo
Search / Trial NCT07071922

User Evaluation of Zelfmoord1813.be and Its Related Websites

Launched by UNIVERSITY GHENT · Jul 8, 2025

Trial Information

Current as of November 09, 2025

Recruiting

Keywords

ClinConnect Summary

This study is looking at how people use and feel about four websites that provide information and support to prevent suicide in Flanders. These websites include Zelfmoord1813.be, which offers crisis help through a free and anonymous helpline, as well as three others that focus on support for those grieving a suicide, helping people in someone’s social circle, and resources specifically for men. The goal is to understand whether visitors find the websites helpful, easy to use, and relevant to their needs. This information will help improve the sites and make sure they reach everyone who might benefit.

If you are 16 years or older and have visited any of these websites, you may be invited to take part in the study. After spending a short time on the site, a small pop-up will ask if you’d like to share your thoughts through a quick, five-minute questionnaire. You can also choose to give feedback later by clicking a link on the website. Your answers will help the people managing these sites make them better and more useful for everyone seeking support or information about suicide prevention.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 16 y/o or older
  • visit(ed) websites zelfmoord1813.be, mee-leven.be, werkgroepverder.be or komuitjekop.be
  • Exclusion Criteria:
  • /

About University Ghent

University Ghent is a prestigious Belgian research institution renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a multidisciplinary approach, the university fosters collaboration among leading experts in various fields, ensuring rigorous study design and ethical standards. University Ghent is dedicated to exploring new therapeutic modalities and enhancing healthcare outcomes, making significant contributions to both local and global health landscapes. Its state-of-the-art facilities and emphasis on research excellence position it as a pivotal sponsor in the realm of clinical research.

Locations

Ghent, Belgium

Patients applied

0 patients applied

Trial Officials

Gwendolyn Portzky, PhD

Principal Investigator

University Ghent

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported